Praxis Precision Medicines, Inc. (PRAX) is a Healthcare stock tracked by StreetAlpha. PRAX reports earnings on Mon, Nov 9, 2026. The average 12-month price target from 5 analysts is $561.40, with a high of $826.00 and a low of $362.00. Analyst consensus is Strong Buy, based on the latest ratings from 5 firms (4 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 3 whale options trades in PRAX, 67% of them bullish and 33% bearish. In the past 30 days there were 5 dark pool prints totaling $6.0M, the largest $2.7M.
Each firm's latest rating on PRAX in the past 90 days
Average 12-month target
$561.40
Based on 5 analysts who set a price target on PRAX in the past 90 days. The average target is $561.40, with a high of $826.00 and a low of $362.00.
Low $362.00Avg $561.40High $826.00
Highest target$826.00
Average target$561.40
Lowest target$362.00
Latest rating changes
BTIGTarget raised
Oct 6Buy$810 → $826
Goldman SachsTarget raised
Aug 21Buy$447 → $575
RBC CapitalTarget raised
Aug 7Buy$449 → $462
Wells FargoMaintained
Aug 7Hold$362
NeedhamTarget raised
Aug 6Buy$575 → $582
Date
Firm
Action
Rating
Price target
Oct 6
BTIG
Target raised
Buy
$810 → $826
Aug 21
Goldman Sachs
Target raised
Buy
$447 → $575
Aug 7
RBC Capital
Target raised
Buy
$449 → $462
Aug 7
Wells Fargo
Maintained
Hold
$362
Aug 6
Needham
Target raised
Buy
$575 → $582
Loading…
Whale Options Flow
90D
Total alerts
3
Bullish
2
67%
Bearish
1
33%
Date span
Aug 6 – Oct 7
Loading…
Dark Pool
30D
Prints
5
Notional
$6.0M
Largest print
$2.7M
Loading…
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PRAX is in one of them and how their past PRAX trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
